U.S. Markets closed

Exelixis (EXEL) Soars: Stock Adds 23% in Session

Zacks Equity Research

Exelixis, Inc. (EXEL) was a big mover last session, as the company saw its shares rise 23% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.25 to $3.71 in the past one-month time frame.

The company has seen no estimate revision in the past 30 days, while its Zacks Consensus Estimate moved lower over the same time frame, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Exelixis currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked medical stocks that are worth considering are Actelion Ltd. (ALIOF), Anthera Pharmaceuticals, Inc. (ANTH) and Biogen Idec Inc. (BIIB). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

EXELIXIS INC (EXEL): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

Zacks Investment Research